<SEC-DOCUMENT>0001019056-21-000500-index.html : 20210923
<SEC-HEADER>0001019056-21-000500.hdr.sgml : 20210923
<ACCEPTANCE-DATETIME>20210923165453
ACCESSION NUMBER:		0001019056-21-000500
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210923
DATE AS OF CHANGE:		20210923
GROUP MEMBERS:		GIL AHARON
GROUP MEMBERS:		ROSALIND ADVISORS, INC.
GROUP MEMBERS:		ROSALIND MASTER FUND L.P.
GROUP MEMBERS:		STEVEN SALAMON

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Unicycive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001766140
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813638692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92874
		FILM NUMBER:		211273069

	BUSINESS ADDRESS:	
		STREET 1:		5150 EL CAMINO REAL, SUITE A-32
		CITY:			LOS ALTOS
		STATE:			CA
		ZIP:			94022
		BUSINESS PHONE:		650-384-0642

	MAIL ADDRESS:	
		STREET 1:		5150 EL CAMINO REAL, SUITE A-32
		CITY:			LOS ALTOS
		STATE:			CA
		ZIP:			94022

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rosalind Advisors, Inc.
		CENTRAL INDEX KEY:			0001622627
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		175 BLOOR STREET EAST
		STREET 2:		SUITE 1316, NORTH TOWER
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W 3R8
		BUSINESS PHONE:		4168887606

	MAIL ADDRESS:	
		STREET 1:		175 BLOOR STREET EAST
		STREET 2:		SUITE 1316, NORTH TOWER
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W 3R8
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>unicycive_13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: unicycive_13g.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>ex_a.htm
<DESCRIPTION>EXHIBIT A
<TEXT>
Document 2 - file: ex_a.htm

</DOCUMENT>
</SEC-DOCUMENT>